Search Results - Jan Burger
- Showing 1 - 11 results of 11
-
1
-
2
P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL by Jan Burger, Ekaterina Kim, Mariela Sivina, Ghayas Issa, Philip Thompson, William G. Wierda, Alessandra Ferrajoli
Published in HemaSphere (2023-08-01)Get full text
Article -
3
P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON OF 3 RANDOMIZED PHASE 3 TRIALS by Paolo Ghia, Talha Munir, Jan Burger, John Seymour, Kerry Rogers, Hsin-Hui Huang, Carol Moreno, Lynne Neumayr, Chris Abbazio, Jeff Sharman
Published in HemaSphere (2023-08-01)Get full text
Article -
4
Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion by Paolo Strati, Michael J. Keating, Susan M. O’Brien, Alessandra Ferrajoli, Jan Burger, Stefan Faderl, Francesco Paolo Tambaro, Nitin Jain, William G. Wierda
Published in Haematologica (2014-08-01)Get full text
Article -
5
Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO by Tobias Berg, Manfred Fliegauf, Jan Burger, Martin S. Staege, Shaohua Liu, Natalia Martinez, Olaf Heidenreich, Stefan Burdach, Torsten Haferlach, Milton H. Werner, Michael Lübbert
Published in Haematologica (2008-11-01)Get full text
Article -
6
Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States by Iman Abou Dalle, Hagop Kantarjian, Jan Burger, Zeev Estrov, Maro Ohanian, Srdan Verstovsek, Farhad Ravandi, Gautam Borthakur, Guillermo Garcia‐Manero, Elias Jabbour, Jorge Cortes
Published in Cancer Medicine (2019-11-01)Get full text
Article -
7
Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma by Steven Coutre, Alessandra Tedeschi, Tadeusz Robak, Paul M. Barr, Carolyn Owen, Osnat Bairey, Jan Burger, Cathy Zhou, Lori Styles, Danelle F. James, Thomas J. Kipps
Published in Haematologica (2018-06-01)Get full text
Article -
8
P644: IBRUTINIB DOSE MODIFICATIONS FOR MANAGEMENT OF CARDIAC ADVERSE EVENTS IN PATIENTS WITH B-CELL MALIGNANCIES: POOLED ANALYSIS OF 10 CLINICAL TRIALS by Deborah Stephens, Jennifer R. Brown, Shuo MA, Michael Wang, Carol Moreno, Tadeusz Robak, Don Stevens, Shane Lee, Chadi Saifan, Emily Hsu, Sima Patel, Jan Burger
Published in HemaSphere (2023-08-01)Get full text
Article -
9
Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets by Ti’ara L. Griffen, Fieke W. Hoff, Yihua Qiu, James W. Lillard, Alessandra Ferrajoli, Philip Thompson, Endurance Toro, Kevin Ruiz, Jan Burger, William Wierda, Steven M. Kornblau
Published in Blood Cancer Journal (2022-03-01)Get full text
Article -
10
A Shared Story: Co-Producing a Life Story Intervention and Research Proposal for People With Severe Mental Health Conditions Living in Inpatient Mental Health Rehabilitation Units... by Mariken Beatrijs de Koning, Annigje van Dijk, Carola van Alphen, Karin Groen, Rembrant Aarts, Mirjam van Til, Thijs Jan Burger, Astrid Vellinga, Ruth Willems, Daan Andriessen, Marlies Welbie, Martine Ganzevles, Lieuwe de Haan, Martijn Kikkert
Published in International Journal of Qualitative Methods (2025-07-01)Get full text
Article -
11
P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY by Nicholas Short, Walid Macaron, Courtney Dinardo, Naval Daver, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia-Manero, Ghayas Issa, Koji Sasaki, Jan Burger, Abhishek Maiti, Yesid Alvarado, Jennifer Thankachan, Regina Abramova, Lewis Nasr, Cedric Nasnas, Marianne Zoghbi, Tapan Kadia, Marina Konopleva, Hagop Kantarjian, Farhad Ravandi
Published in HemaSphere (2023-08-01)Get full text
Article
